Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01998581 · ClinicalTrials.gov registry record · NA
A Safety and Effectiveness Study of JUVÉDERM VOLBELLA® XC Injectable Gel for Lip and Perioral Enhancement
A NA study, sponsored by Allergan.
- Completed
- Registry status
- NA
- Development phase
- 225
- Enrollment target
NCT01998581 is a NA study that has completed, run by Allergan. The registered enrollment target is 225 participants.
The verdict
NCT01998581, a NA study, has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- NA
- Development phase
- 225 participants
- Enrollment target
Study Summary
This is a multicenter, double-blind, randomized, controlled study of the safety and effectiveness of JUVÉDERM VOLBELLA® XC Injectable Gel versus Restylane-L® for lip and perioral enhancement.
Interventions
- DEVICE Restylane-L®
- DEVICE JUVEDERM VOLBELLA® XC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2013-11-01 |
| Est. Completion | 2015-05-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01998581
The ClinicalTrials.gov registry entry for NCT01998581 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Restylane-L® is the first listed.
NCT01998581 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01998581 about?
NCT01998581 is a clinical study titled "A Safety and Effectiveness Study of JUVÉDERM VOLBELLA® XC Injectable Gel for Lip and Perioral Enhancement". This is a multicenter, double-blind, randomized, controlled study of the safety and effectiveness of JUVÉDERM VOLBELLA® XC Injectable Gel versus Restylane-L® for lip and perioral enhancement.
What is the current status of trial NCT01998581?
This trial is currently completed. It is a NA study. The enrollment target is 225 participants. The study started on 2013-11-01. Estimated completion is 2015-05-29.
What interventions are being tested in trial NCT01998581?
The interventions under investigation include: Restylane-L® (DEVICE), JUVEDERM VOLBELLA® XC (DEVICE).
Who is sponsoring clinical trial NCT01998581?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.